ALFA Filings
Every announcement, straight from the exchange
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
Announcement type
Time
4 announcements with these filters
Zota reported 67.6% YoY revenue growth in Q1 FY27, driven by Davaindia network expansion. Management expects EBITDA positivity to resume from Q2 and cash breakeven by Q1 FY28.
Zota Health Care's Q1FY27 presentation highlights its massive Davaindia retail generic pharmacy expansion, now reaching 2,825 stores and driving 83% of company revenue.
Zota reported robust FY26 performance with 83.86% revenue growth, achieving EBITDA turnaround and significant Davaindia store expansion to 2,579 outlets.
Zota Health Care (FY26) achieved ₹53,865.75 lakhs revenue, driven by its Davaindia generic pharmacy retail chain which now spans 2,579 stores across 23 states.